MEDICLIN Aktiengesellschaft (MED.DE)
EUR 2.42
(0.0%)
EUR 2.42
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 12.72 Million EUR | -212.98% |
| 2022 | 19.51 Million EUR | 68.81% |
| 2021 | 11.56 Million EUR | 3692.74% |
| 2020 | 304.87 Thousand EUR | -98.64% |
| 2019 | 22.41 Million EUR | 48.79% |
| 2018 | 15.06 Million EUR | 127.67% |
| 2017 | 6.61 Million EUR | -72.46% |
| 2016 | 24.02 Million EUR | 1.75% |
| 2015 | 23.6 Million EUR | 51.7% |
| 2014 | 15.56 Million EUR | 624.59% |
| 2013 | 2.14 Million EUR | -49.79% |
| 2012 | 4.27 Million EUR | -60.63% |
| 2011 | 10.86 Million EUR | -35.59% |
| 2010 | 16.86 Million EUR | -0.55% |
| 2009 | 16.96 Million EUR | 7.36% |
| 2008 | 15.79 Million EUR | -16.25% |
| 2007 | 18.86 Million EUR | 12.81% |
| 2006 | 16.72 Million EUR | 3.89% |
| 2005 | 16.09 Million EUR | -94.26% |
| 2004 | 280.54 Million EUR | -0.15% |
| 2003 | 280.96 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 7.85 Million EUR | 91.9% |
| 2024 Q1 | 4.09 Million EUR | 124.56% |
| 2023 Q4 | -16.66 Million EUR | -189.74% |
| 2023 Q2 | 12.93 Million EUR | 917.87% |
| 2023 Q3 | 18.56 Million EUR | 43.51% |
| 2023 Q1 | -1.58 Million EUR | -116.77% |
| 2023 FY | -22.05 Million EUR | -212.98% |
| 2022 Q3 | 3.51 Million EUR | -61.91% |
| 2022 FY | 19.51 Million EUR | 68.81% |
| 2022 Q1 | -2.64 Million EUR | -125.97% |
| 2022 Q4 | 9.43 Million EUR | 168.21% |
| 2022 Q2 | 9.23 Million EUR | 449.12% |
| 2021 Q1 | -11.85 Million EUR | -538.84% |
| 2021 Q2 | -1.55 Million EUR | 86.86% |
| 2021 Q3 | 14.79 Million EUR | 1049.74% |
| 2021 Q4 | 10.18 Million EUR | -31.19% |
| 2021 FY | 11.56 Million EUR | 3692.74% |
| 2020 Q4 | -1.85 Million EUR | -117.23% |
| 2020 FY | 304.87 Thousand EUR | -98.64% |
| 2020 Q3 | 10.77 Million EUR | 321.44% |
| 2020 Q2 | -4.86 Million EUR | -24.72% |
| 2020 Q1 | -3.9 Million EUR | -151.62% |
| 2019 Q2 | 4.52 Million EUR | 178.9% |
| 2019 Q4 | 7.55 Million EUR | -13.31% |
| 2019 FY | 22.41 Million EUR | 48.79% |
| 2019 Q1 | 1.62 Million EUR | 160.12% |
| 2019 Q3 | 8.71 Million EUR | 92.77% |
| 2018 Q4 | -2.69 Million EUR | -123.56% |
| 2018 FY | 15.06 Million EUR | 127.67% |
| 2018 Q1 | 675 Thousand EUR | 105.3% |
| 2018 Q2 | 5.64 Million EUR | 735.56% |
| 2018 Q3 | 11.44 Million EUR | 102.91% |
| 2017 Q4 | -12.74 Million EUR | -192.77% |
| 2017 Q3 | 13.73 Million EUR | 125.15% |
| 2017 Q2 | 6.1 Million EUR | 1378.83% |
| 2017 Q1 | -477 Thousand EUR | -107.69% |
| 2017 FY | 6.61 Million EUR | -72.46% |
| 2016 Q1 | 1.69 Million EUR | -72.43% |
| 2016 Q2 | 7.4 Million EUR | 335.55% |
| 2016 Q3 | 8.72 Million EUR | 17.88% |
| 2016 Q4 | 6.2 Million EUR | -28.91% |
| 2016 FY | 24.02 Million EUR | 1.75% |
| 2015 Q4 | 6.16 Million EUR | -43.33% |
| 2015 FY | 23.6 Million EUR | 51.7% |
| 2015 Q3 | 10.87 Million EUR | 118.29% |
| 2015 Q2 | 4.98 Million EUR | 212.68% |
| 2015 Q1 | 1.59 Million EUR | -52.92% |
| 2014 Q2 | 4.12 Million EUR | 494.27% |
| 2014 Q1 | -1.04 Million EUR | -3375.86% |
| 2014 Q4 | 3.38 Million EUR | -62.82% |
| 2014 Q3 | 9.09 Million EUR | 120.42% |
| 2014 FY | 15.56 Million EUR | 624.59% |
| 2013 Q2 | 2.3 Million EUR | 139.08% |
| 2013 Q4 | -30.12 Thousand EUR | -100.52% |
| 2013 FY | 2.14 Million EUR | -49.79% |
| 2013 Q1 | -5.9 Million EUR | -214.39% |
| 2013 Q3 | 5.77 Million EUR | 150.28% |
| 2012 Q2 | 2.21 Million EUR | 291.6% |
| 2012 Q3 | 5.09 Million EUR | 130.28% |
| 2012 Q4 | -1.87 Million EUR | -136.84% |
| 2012 FY | 4.27 Million EUR | -60.63% |
| 2012 Q1 | -1.15 Million EUR | -130.11% |
| 2011 Q2 | 1.77 Million EUR | 431.03% |
| 2011 Q4 | 3.83 Million EUR | -27.07% |
| 2011 Q1 | -535 Thousand EUR | -111.28% |
| 2011 FY | 10.86 Million EUR | -35.59% |
| 2011 Q3 | 5.25 Million EUR | 196.95% |
| 2010 Q4 | 4.74 Million EUR | -34.14% |
| 2010 Q3 | 7.2 Million EUR | 45.58% |
| 2010 Q2 | 4.94 Million EUR | 20712.5% |
| 2010 Q1 | -24 Thousand EUR | -100.66% |
| 2010 FY | 16.86 Million EUR | -0.55% |
| 2009 Q4 | 3.63 Million EUR | -54.79% |
| 2009 FY | 16.96 Million EUR | 7.36% |
| 2009 Q1 | -63 Thousand EUR | 0.0% |
| 2009 Q3 | 8.03 Million EUR | 49.87% |
| 2009 Q2 | 5.36 Million EUR | 8607.94% |
| 2008 FY | 15.79 Million EUR | -16.25% |
| 2007 FY | 18.86 Million EUR | 12.81% |
| 2006 FY | 16.72 Million EUR | 3.89% |
| 2005 FY | 16.09 Million EUR | -94.26% |
| 2004 FY | 280.54 Million EUR | -0.15% |
| 2003 FY | 280.96 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 1.36 Billion EUR | 99.071% |
| Fresenius SE & Co. KGaA | 1.14 Billion EUR | 98.887% |
| LIMES Schlosskliniken AG | 5.02 Million EUR | -153.125% |
| M1 Kliniken AG | 15.69 Million EUR | 18.969% |
| Maternus-Kliniken Aktiengesellschaft | -9.26 Million EUR | 237.384% |
| RHÖN-KLINIKUM Aktiengesellschaft | 40.39 Million EUR | 68.51% |
| VITA 34 AG | -3.12 Million EUR | 507.749% |